Advances in mammalian target of rapamycin kinase inhibitors: application to devices used in the treatment of coronary artery disease

Mammalian target of rapamycin (mTOR) inhibitors have been applied to vascular coronary devices to avoid neointimal growth and have become the predominant pharmacological agents used to prevent restenosis. mTOR inhibitors can affect not only proliferating vascular smooth muscle cells but also endothe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Future Med Chem
Egile Nagusiak: Jinnouchi, Hiroyuki, Guo, Liang, Sakamoto, Atsushi, Sato, Yu, Cornelissen, Anne, Kawakami, Rika, Mori, Masayuki, Torii, Sho, Kuntz, Salome, Harari, Emanuel, Mori, Hiroyoshi, Fuller, Daniela, Gadhoke, Neel, Fernandez, Raquel, Paek, Ka Hyun, Surve, Dipti, Romero, Maria, Kolodgie, Frank D, Virmani, Renu, Finn, Aloke V
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Newlands Press Ltd 2020
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7333590/
https://ncbi.nlm.nih.gov/pubmed/32431177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc-2019-0304
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak